Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded tRNA glutamic acid (MT-TE, also called trnE or tRNAGlu) is a transfer RNA molecule encoded within human mitochondrial DNA. It consists of 68–69 nucleotides and functions by transferring the amino acid glutamic acid during mitochondrial protein synthesis, which is crucial for the assembly of proteins involved in oxidative phosphorylation, the process that produces cellular ATP. MT-TE is expressed exclusively in the mitochondria and essential for normal mitochondrial function and cellular energy homeostasis. Pathogenic mutations in MT-TE are associated with mitochondrial disorders including maternally inherited diabetes and deafness, mitochondrial myopathies, MELAS, and sometimes Leber's hereditary optic neuropathy. The molecule itself is not considered a therapeutic target (such as a receptor or enzyme), but its genetic integrity is critical for normal energy metabolism, and its mutations serve as diagnostic biomarkers for certain mitochondrial diseases.
Not applicable; transfer RNAs are not direct drug targets in clinical use. Pathology arises from mutations affecting protein translation and subsequent mitochondrial dysfunction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded tRNA glutamic acid (MT-TE).